Germline mutations in 5' to c.7914 of BRCA2 significantly increase risk of prostate cancer
Main Authors: | Xiao-Hao Ruan, Da Huang, Xiao-Ling Lin, Zu-Jun Fang, Qiang Ding, Yi-Shuo Wu, Rong Na |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Asian Journal of Andrology |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=3;spage=433;epage=434;aulast= |
Similar Items
-
Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01) -
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
by: Felice Crocetto, et al.
Published: (2021-05-01) -
Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients
by: Wei Chen, et al.
Published: (2022-02-01) -
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
by: Renea A. Taylor, et al.
Published: (2017-01-01) -
Overview on population screening for carriers with germline BRCA mutation in China
by: Huijun Lei, et al.
Published: (2022-11-01)